Announcements Trials

Browse Landscape

Phase

Status

Recruiting 2 Unknown 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 21 Leukemia, Myeloid, Acute 20 Lymphoma, Non-Hodgkin 19 Hodgkin Disease 18 Multiple Myeloma 17 Myelodysplastic Syndromes 16 Lymphoma 16 Graft vs Host Disease 16 Lymphoma, Mantle-Cell 15 Leukemia, Lymphocytic, Chronic, B-Cell 15 Leukemia 14 Sarcoma 11 Lymphoma, Large B-Cell, Diffuse 11 Lymphoma, Follicular 11 Glioblastoma 11 Tuberous Sclerosis 10 Lymphoma, B-Cell, Marginal Zone 10 Carcinoma, Renal Cell 10 Neoplasms 9 Hematologic Neoplasms 9 Gliosarcoma 9 Carcinoma, Hepatocellular 9 Breast Neoplasms 9 Brain Neoplasms 9 Waldenstrom Macroglobulinemia 8 Myeloproliferative Disorders 8 Melanoma 8 Burkitt Lymphoma 8 Recurrence 7 Neoplasm Metastasis 7

Interventions

LY3295668 erbumine 2 Everolimus 2 ziprasidone 1 enzalutamide 1 clevidipine 1 Zolpidem 1 Warfarin 1 Vecuronium Bromide 1 Vancomycin 1 Tranexamic Acid 1 Tobramycin 1 Spironolactone 1 Sirolimus 1 Sevoflurane 1 Sevelamer 1 Saline Solution 1 Rocuronium 1 Propofol 1 Piperacillin, Tazobactam Drug Combination 1 Pentobarbital 1 Oxycodone 1 Nitrous Oxide 1 Nifedipine 1 Nafcillin 1 Molindone 1 Midazolam 1 Methylprednisolone 1 Mass Screening 1 Lurasidone Hydrochloride 1 Lidocaine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Epilepsy × Sirolimus × Clear all

NCT04595513 2024-05-16

STOP2

Children's Hospital Medical Center, Cincinnati

Phase 1/2 Completed

5 enrolled 15 charts

Epilepsy, Tuberous Sclerosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡